Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Lorber

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cureus|March 28, 2018
A Lymphoma Almost OverlookedJeremy Lorber, Martina Zalom
Cancer Genetics|February 9, 2025
De novo RUNX1-driven acute myeloid leukemia requiring integrative geneticsCeleste C Eno, Jeremy Lorber, Eric Vail, et al.
Advances in Skin & Wound Care|June 20, 2024
Nonhealing Surgical Wounds in a Patient with Plasminogen Deficiency Type 1 Successfully Treated with Intravenous Plasminogen: A Case ReportRobert Wayne Decker, Joseph Mickler Parker, Jeremy Lorber, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 18, 2025
Safety and Efficacy of Long-Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement TherapyAmy D Shapiro, Heather McDaniel, Robert W Decker, et al.
American Journal of Hematology|April 30, 2024
Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher RegistryPramod K Mistry, Manisha Balwani, Joel Charrow, et al.
Biomedicines|May 27, 2023
Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study ProtocolJun Gong, Arsen Osipov, Jeremy Lorber, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cureus|March 28, 2018
A Lymphoma Almost OverlookedJeremy Lorber, Martina Zalom
Cancer Genetics|February 9, 2025
De novo RUNX1-driven acute myeloid leukemia requiring integrative geneticsCeleste C Eno, Jeremy Lorber, Eric Vail, et al.
Advances in Skin & Wound Care|June 20, 2024
Nonhealing Surgical Wounds in a Patient with Plasminogen Deficiency Type 1 Successfully Treated with Intravenous Plasminogen: A Case ReportRobert Wayne Decker, Joseph Mickler Parker, Jeremy Lorber, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 18, 2025
Safety and Efficacy of Long-Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement TherapyAmy D Shapiro, Heather McDaniel, Robert W Decker, et al.
American Journal of Hematology|April 30, 2024
Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher RegistryPramod K Mistry, Manisha Balwani, Joel Charrow, et al.
Biomedicines|May 27, 2023
Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study ProtocolJun Gong, Arsen Osipov, Jeremy Lorber, et al.
Pageof 1